Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 1, Single-Dose, Open-Label, Two-Period, Randomised, Crossover Study Assessing the Effect of Food (Fasted or Fed State) on Pharmacokinetics of Fenfluramine (ZX008) Oral Solution in Healthy Subjects

Trial Profile

A Phase 1, Single-Dose, Open-Label, Two-Period, Randomised, Crossover Study Assessing the Effect of Food (Fasted or Fed State) on Pharmacokinetics of Fenfluramine (ZX008) Oral Solution in Healthy Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 22 Jun 2018

At a glance

  • Drugs Fenfluramine (Primary)
  • Indications Dravet syndrome; Epilepsy; Lennox-Gastaut syndrome
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Zogenix
  • Most Recent Events

    • 22 Jun 2018 Results published in the Clinical Therapeutics Journal.
    • 03 Jan 2018 New trial record
    • 05 Dec 2017 Results presented at the 71st Annual Meeting of the American Epilepsy Society.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top